Aravive

$4.60
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.32 (-6.50%) As of 11:15 AM EDT today

Why Robinhood?

You can buy or sell Aravive and other stocks, options, and ETFs commission-free!

About ARAV

Aravive, Inc. Common Stock, also called Aravive, is a clinical-stage biotechnology company, which engages in developing new therapies that target important survival pathways for both advanced solid tumors as well as hematologic malignancies. Read More Its product candidate, Aravive-S6, is a soluble Fc-fusion protein designed to block the activation of the GAS6-AXL signaling pathway by intercepting the binding of GAS6 to its receptor AXL which also promotes metastasis, cancer cell survival, resistance to treatments, and immune suppression. The company was founded on December 10, 2008 and is headquartered in Houston, TX. The listed name for ARAV is Aravive, Inc. Common Stock.

Employees
17
Headquarters
Houston, Texas
Founded
2008
Market Cap
74.13M
Price-Earnings Ratio
Dividend Yield
Average Volume
99.93K
High Today
$4.76
Low Today
$4.54
Open Price
$4.76
Volume
75.13K
52 Week High
$15.62
52 Week Low
$3.34

Collections

ARAV Earnings

-$0.72
-$0.48
-$0.24
$0.00
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Estimated
per share
Actual
Expected Mar 26, Pre-Market

You May Also Like